miniVec™ 2025 Promotion

Don't wait — order your miniVec™ vectors today and
pay $0 in R&D license fees!

Start Your miniVec^TM Project Today

Our miniVec™ plasmid offers a miniaturized backbone, providing remarkable efficacy, safety, and manufacturability. Compared to traditional plasmids, miniVec™ plasmids have higher plasmid manufacturing yields and transgene expression, enhance performance in various applications, and demonstrate a better safety profile. The miniVec™ backbone supports antibiotic-free and supplement-free selection and can be applied across diverse expression systems.

In response to the overwhelming interest from the CGT research community, VectorBuilder is offering a special promotion for its proprietary miniVec™ technology. VectorBuilder will waive 100% of internal R&D license fees for all purchases of the miniVec™ plasmid that are made through the end of 2025*. 

View our miniVec™ offerings >>

* Terms and Conditions 

• The waiver only applies to miniVec™ vectors ordered between October 9, 2025 and December 31, 2025.
• The waiver only applies to internal R&D license (license fees for clinical use of the constructs and/or commercialization are not waived).
• Academic and industrial/pharmaceutical clients are both eligible for this promotion.
• Additional terms and conditions pertaining to the use and distribution of  miniVec™ products may be requested by contacting us.